US20030229391A1 - Stent - Google Patents
Stent Download PDFInfo
- Publication number
- US20030229391A1 US20030229391A1 US10/389,273 US38927303A US2003229391A1 US 20030229391 A1 US20030229391 A1 US 20030229391A1 US 38927303 A US38927303 A US 38927303A US 2003229391 A1 US2003229391 A1 US 2003229391A1
- Authority
- US
- United States
- Prior art keywords
- stent
- segments
- stent body
- widths
- deployed orientation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/89—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91508—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
- A61F2002/91541—Adjacent bands are arranged out of phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91575—Adjacent bands being connected to each other connected peak to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0036—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in thickness
Definitions
- This invention pertains to stents for use in intraluminal applications. More particularly, this invention pertains to a novel structure for such stents.
- Stents are widely used for numerous applications where the stent is placed in the lumen of a patient and expanded. Such stents may be used in coronary or other vasculature, as well as other body lumens.
- stents are cylindrical members.
- the stents expand from reduced diameters to enlarged diameters.
- stents are placed on a balloon catheter with the stent in the reduced-diameter state. So placed, the stent is advanced on the catheter to a placement site. At the site, the balloon is inflated to expand the stent to the enlarged diameter. The balloon is deflated and removed, leaving the enlarged diameter stent in place. So used, such stents are used to expand occluded sites within a patient's vasculature or other lumen.
- the stent In stent design, it is desirable for the stent to be flexible along its longitudinal axis to permit passage of the stent through arcuate segments of a patient's vasculature or other body lumen. Preferably, the stent will have at most minimal longitudinal shrinkage when expanded and will resist compressive forces once expanded.
- the present disclosure relates to a stent including a stent body having a stent axis.
- the stent body includes structural members that define openings through the stent body.
- the structural members are provided with regions having different widths.
- the relative sizes of the widths are selected to control the length of the stent body as the stent body is radially expanded from an un-deployed orientation to a deployed orientation.
- the regions having different widths are provided by tapering the widths of selected segments of the structural member.
- the relative sizes of the widths are selected to minimize or eliminate length changes as the stent body is expanded from the un-deployed orientation to the expanded orientation.
- FIG. 1 is a perspective view of a first embodiment of a stent according to the present invention shown in a rest diameter state and showing a plurality of stent cells each having a major axis perpendicular to an axis of the stent;
- FIG. 4 is a view taken along line 4 - 4 in FIG. 2;
- FIG. 5 is a view taken along line 5 - 5 in FIG. 2;
- FIG. 6 is an enlarged view of a portion of FIG. 2 illustrating a cell structure with material of the stent surrounding adjacent cells shown in phantom lines;
- FIG. 7 is the view of FIG. 2 showing an alternative embodiment of the present invention with a cell having five peaks per longitudinal segment;
- FIG. 10 is a plan view of another stent as it would appear if it were longitudinally split and laid out flat;
- FIG. 12 is a plan view of a portion of the stent of FIG. 10 in a deployed/expanded orientation, the stent has been longitudinally cut and laid flat.
- FIG. 1 illustrates a stent 10 having a rest length L r and an un-deployed or reduced diameter D r .
- locations A, B, C, D, E, F and G are shown severed from their normally integrally formed locations A 1 , B 1 , C 1 , D 1 , E 1 , F 1 and G 1 .
- length L e is preferably not more than minimally smaller (e.g., less than 10% smaller) than length L r . Ideally, L e equals L r .
- the material of the stent 10 defines a plurality of cells 12 .
- the cells 12 are bounded areas which are open (i.e., extend through the wall thickness of the stent 10 ).
- the stent 10 may be formed through any suitable means including laser or chemical milling. In such processes, a hollow cylindrical tube is milled to remove material and form the open cells 12 .
- the cells 12 have a longitudinal or major axis X M -X M and a transverse or minor axis X m -X m .
- the major axis X M -X M is perpendicular to the longitudinal cylindrical axis X-X of the stent 10 .
- the major axis X M ′-X M ′ is parallel to the longitudinal cylindrical axis X′-X′ of the stent 10 ′.
- the cell 12 is symmetrical about axes X M -X M and X m -X m .
- the cell 12 is defined by portions of the tube material including first and second longitudinal segments 14 .
- the segments 14 each have a longitudinal axis X a -X a as shown in FIG. 6.
- the segments' longitudinal axes X a -X a are parallel to and positioned on opposite sides of the cell major axis X M -X M .
- Each of longitudinal segments 14 has an undulating pattern to define a plurality of peaks 17 , 21 , 25 and valleys 19 , 23 .
- the peaks 17 , 21 , 25 are spaced outwardly from the longitudinal axes X a -X a and the valleys 19 , 23 are spaced inwardly from the longitudinal axes X a -X a .
- “inward” and “outward” mean toward and away from, respectively, the cell's major axis X M -X M .
- Each of the peaks 17 , 21 , 25 and valleys 19 , 23 is a generally semi-circular arcuate segment.
- the peaks 17 , 21 , 25 and valleys 19 , 23 are joined by parallel and spaced-apart straight segments 16 , 18 , 20 , 22 , 24 and 26 which extend perpendicular to the major axis X M -X M .
- Linearly aligned straight end portions 16 , 26 of opposing segments 14 are joined at first and second longitudinal connection locations 27 spaced apart on the major axis X M -X M .
- First and second transverse connection locations 28 are spaced apart on the minor axis X m -X m .
- the first and second transverse connection locations 28 are positioned at the apices of the center peaks 21 of the longitudinal segments 14 .
- width W′ (FIG. 5) at the apices of the peaks 17 , 21 , 25 and valleys 19 , 23 is narrower than width W (in the example given, narrow width W′ is about 0.0055 inch or about 0.13 mm).
- the width of the peaks 17 , 21 , 25 and valleys 19 , 23 gradually increases from width W′ at the apices to width W at the straight segments 16 , 18 , 20 , 22 , 24 and 26 .
- the width W C (shown in FIG. 2) is preferably equal to or less than the common width W.
- the combined lengths of segments 16 - 20 to the apex of peak 21 represent a path length 50 from longitudinal connection location 27 to transverse connection location 28 .
- the combined lengths of the other arcuate and straight segments 22 - 26 to the apex of peak 21 represent identical length path lengths 51 of identical geometry from longitudinal connection locations 27 to transverse connection locations 28 .
- Each of the path lengths 50 , 51 is longer than a straight-line distance between the transverse and longitudinal connection locations 27 , 28 .
- the straight-line distance between the transverse and longitudinal connection locations 27 , 28 increases as the diameter of the stent 10 is expanded.
- the path lengths 50 , 51 are sized to be not less than the expanded straight-line distance.
- the stent 10 includes a plurality of identical cells 12 . Opposite edges of the segments 14 define obliquely adjacent cells (such as cells 12 1 , 12 2 in FIG. 2). Cells 12 having major axes X M -X M collinear with the major axis X M -X M of cell 12 are interconnected at the longitudinal connection locations 27 . Cells having minor axes collinear with the minor axis X m -X m of cell 12 are interconnected at the transverse connection locations 28 .
- the stent 10 in the reduced diameter of FIG. 1 is advanced to a site in a lumen.
- the stent 10 is then expanded at the site.
- the stent 10 may be expanded through any conventional means.
- the stent 10 in the reduced diameter may be placed on the balloon tip of a catheter.
- the balloon is expanded to generate radial forces on the interior of the stent 10 .
- the radial forces urge the stent 10 to radially expand without appreciable longitudinal expansion or contraction.
- Plastic deformation of the material of the stent 10 e.g., stainless steel
- the stent 10 may be formed of a super-elastic or shape memory material (such as nitinol—a well-known stent material which is an alloy of nickel and titanium).
- FIG. 3 illustrates the straightening of the path lengths 50 , 51 .
- the stent 10 has been only partially expanded to an expanded diameter less than a maximum expanded diameter.
- the path lengths 50 , 51 are fully straight. Further expansion of the stent 10 beyond the maximum expanded size would result in narrowing of the minor axis X m -X m (i.e., a narrowing of a separation between the transverse connection locations and a resulting narrowing of the length L r of the stent) or would require stretching and thinning of the stent material.
- the cells 12 assume a diamond shape shown in FIG. 3. Since the expansion forces are radial, the length of the major axis X M -X M (i.e., the distance between the longitudinal connection locations 27 ) increases. The length of the minor axis X m -X m (and hence the length of the stent 10 ) remains unchanged.
- the stent 10 is highly flexible. To advance to a site, the axis X-X of the stent 10 must bend to navigate through a curved lumen. Further, for placement at a curved site in a lumen, the stent 10 must be sufficiently flexible to retain a curved shape following expansion and to bend as the lumen bends over time. The stent 10 , as described above, achieves these objections.
- the stent 10 may be lined with either an inner or outer sleeve (such as polyester fabric or ePTFE) for tissue growth.
- the stent may be coated with radiopaque coatings such as platinum, gold, tungsten or tantalum.
- the stent may be formed of any one of a wide variety of previous known materials including, without limitation, MP35N, tantalum, platinum, gold, Elgiloy and Phynox.
- FIG. 7 illustrates a stent 10 ′′ with a cell 12 ′′ having five peaks 117 ′′, 17 ′′, 21 ′′, 25 ′′ and 125 ′′ per longitudinal segment 14 ′′.
- the longitudinal segment will have an odd number of peaks so that the transverse connection points are at an apex of a center peak.
- FIGS. 8 and 9 illustrate an alternative embodiment where the major axis X M ′-X M ′ of the cells 12 ′ are parallel with the cylindrical axis X′-X′ of the stent 10 ′.
- the expanded stent 10 ′ is shown at a near fully expanded state where the path lengths 50 ′, 51 ′ are substantially linear.
- the stent When forming the stent from shape memory metal such as nitinol, the stent can be laser cut from a nitinol tube. Thereafter, the stent can be subjected to a shape-setting process in which the cut tube is expanded on a mandrel and then heated. Multiple expansion and heating cycles can be used to shape-set the stent to the final expanded diameter. Preferably, the final expanded diameter is equal to the desired deployed diameter of the stent. During expansion, the stent is preferably axially restrained such that the length of the stent does not change during expansion. The finished stent preferably has an austenite finish temperature less than body temperature. Thus, at body temperature, the stent will self-expand to the desired deployed diameter due to the shape memory characteristic of the metal forming the stent.
- the finished stent can be mounted on a delivery catheter.
- the stent can be held in a compressed orientation on the delivery catheter by a retractable sheath.
- the delivery catheter can be used to advance the stent to a deployment location (e.g., a constricted region of a vessel). At the deployment cite, the sheath is retracted thereby releasing the stent. Once released, the stent self-expands to the deployed diameter.
- the lengths of prior art stents when mounted on a delivery catheter can be different from the deployed lengths of such stents.
- the deployed lengths of the prior art stents are often shorter than the compressed orientation lengths (i.e., the lengths of the stents when mounted on a delivery catheter). Shortening can be problematic because shortening makes it more difficult for a physician to accurately place a stent at a desired position in a vessel.
- An important aspect of the present invention relates to a stent design that reduces or eliminates shortening of a stent.
- one embodiment of the present invention relates to a stent having the same length or substantially the same length at each of the following stages: 1) when the stent is initially cut from a tube of shape-memory alloy; 2) when the stent is shape-set to the desired expanded diameter; 3) when the stent is compressed on the delivery catheter; and 4) when the stent is deployed at a deployment location.
- the segments 16 , 18 , 20 , 22 , 24 and 26 controls whether the stent shortens, lengthens, or remains the same length during expansion from the compressed orientation (i.e., the reduced diameter orientation) to the deployed orientation.
- the segments 26 and 16 are preferably constructed with enlarged widths adjacent the connection locations 27 , and reduced widths adjacent their corresponding peaks 25 and 17 .
- the segments 22 and 20 are preferably constructed with enlarged widths adjacent the connection locations 28 , and reduced widths adjacent their corresponding valleys 23 and 19 . The relative sizes between the enlarged widths and the reduced widths controls whether the stent shortens, lengthens, or remains the same during expansion.
- FIGS. 10 - 12 show a stent 210 having a cell structure adapted to limit any length changes that may occur as the stent is expanded from the compressed orientation to the deployed orientation.
- the length change between the compressed orientation and the deployed orientation is less than 5 percent. More preferably, the length change between the compressed orientation and the deployed orientation is less than 2 percent.
- the stent 210 experiences substantially no length change as it is released from a delivery catheter and expanded from the compressed orientation to the deployed orientation.
- FIG. 10 shows the stent 210 cut longitudinally along its length and laid flat.
- the stent 210 has a length L and a circumference C.
- FIG. 10 is representative of the stent 210 after the stent 210 has been laser cut from a shape-memory tube, but before the stent 210 has been shape-set to the expanded diameter.
- FIG. 12 shows a portion of the stent 210 after the stent has be shape-set to the desired expanded diameter.
- the stent 210 is elongated along axis A-A and includes a stent body (i.e., a three-dimensional structure) having cell defining portions that define plurality of cells 212 .
- a stent body i.e., a three-dimensional structure
- the cells 212 are preferably more open than the cells 212 depicted in FIG. 10. However, while the circumference C increases, the length L preferably remains substantially the same at both diameters.
- the cell defining portions of the stent body include circumferential connection locations 227 and longitudinal connection locations 228 .
- “Circumferential connection locations” are locations where circumferentially adjacent cell defining structures, as defined relative to axis A-A, are connected together.
- “Longitudinal connection locations” are locations where longitudinally adjacent cell defining portions, as define relative to the axis A-A, are connected together.
- each cell defining portion includes two axially spaced-apart members 214 (i.e., members that are spaced-apart from one another along the axis A-A) that extend circumferentially about the axis A-A in an undulating pattern.
- the members 214 extend in the undulating pattern between the circumferential connection locations 227 . Adjacent the circumferential connection locations 227 , the ends of the undulating members 214 are connected to one another. At the longitudinal connection locations 228 , the undulating members 214 merge with the undulating members 214 of longitudinally adjacent cell defining portions.
- each undulating member 214 is shown including: 1) a segment 226 that extends from connection location 227 to peak 225 ; 2) a segment 224 that extends from peak 225 to valley 223 ; 3) a segment 222 that extends from valley 223 to connection location 228 ; 4) a segment 220 that extends from connection location 228 to valley 219 ; 5) a segment 218 that extends from valley 219 to peak 217 ; and 6) a segment 216 that extends from peak 217 to connection location 227 .
- the segments 216 - 226 preferably extend generally longitudinally along the stent 210 .
- the term “generally longitudinally” will be understood to mean that the segments 216 - 226 are closer to a parallel relationship relative to the axis A-A of the stent 210 than to a transverse relationship relative to the axis A-A of the stent 210 .
- the segments 226 and 216 preferably include enlarged widths W 1 adjacent the connection locations 227 , and reduced widths W 2 adjacent their corresponding peaks 225 and 217 .
- the segments 222 and 220 are preferably constructed with enlarged widths W 1 adjacent the connection locations 228 , and reduced widths W 2 adjacent their corresponding valleys 223 and 219 .
- widths of the segments 226 , 222 , 220 and 216 taper (i.e., narrow) continuously along their lengths. As is clear from FIG. 11, the widths of the segments are measured in a circumferential direction relative to the axis A-A.
- pairs of tapered segments 226 and 216 are provided at each circumferential connection location 227
- pairs of tapered segments 222 and 220 are provided at each longitudinal connection location 228 .
- Each pair of tapered segments is defined by an inner cut 250 that is parallel to the axis A-A of the stent 210 , and two outer cuts 252 that are angled relative to the axis A-A of the stent 210 .
- the outer cuts 252 diverge from one another as the cuts 252 extend toward their corresponding connection location 227 or 228 .
- the angled orientation of the cuts 252 causes the segments 224 and 218 which interconnect the pairs of tapered segments 226 , 216 , 222 and 220 to have a non-tapered configuration. Additionally, the angled orientation of the cuts 252 causes the segments 224 and 218 to be angled (i.e., skewed) relative to the axis A-A of the stent 210 .
- the narrowing from width W 1 to W 2 results in a taper along the lengths of the segments 226 , 222 , 220 and 216 .
- the taper has an angle B in the range of 0.5-5 degrees relative to the axis A-A of the stent 210 . More preferably, the taper angle B is in the range of 1-3 percent. It has been found that the relative sizes of W 1 and W 2 have an effect on the deployed length of the stent 210 (i.e., the length of the stent after deployment in a vessel) as compared to the compressed length of the stent 210 (i.e., the length of the stent when mounted on a delivery catheter).
- the widths W 1 and W 2 can be selected to effect a desired change in length including no change in length if so desired.
- a stent having a 5 millimeter cell length L c (labeled on FIG. 11), a first width W 1 of 0.0065 inch and a second width W 2 of 0.0059 inch has been found to lengthen about 10% during expansion from the compressed orientation to the deployed orientation.
- a stent having a 5 millimeter cell length L c (labeled on FIG. 11), a first width W 1 of 0.009 and a second width W 2 of 0.0047, has been found to shorten about 10% during expansion from the compressed orientation to the deployed orientation.
- a stent with a 5 millimeter cell length L c (labeled on FIG. 11), a first width W 1 of 0.008 inches, a second width W 2 of 0.0052 inches and an angle B of two degrees has been found to experience no lengthening and no shortening when expanded from the compressed orientation and the deployed orientation.
- FIGS. 10 - 12 While a preferred use for the inventive features disclosed in FIGS. 10 - 12 is in a self-expanding stent, the features also have benefits when used with non-self-expanding stents (e.g., balloon expandable stents made of a material such as stainless steel). Also, while FIGS. 10 - 12 illustrate a preferred geometry for practicing the present invention, the technique for controlling length variations by varying the widths of selected portions of a stent is also applicable to stents having other geometries, shapes, or strut patterns. Further, the various aspects of the present invention can also be used to cause a desired shortening or lengthening of a stent during deployment.
- non-self-expanding stents e.g., balloon expandable stents made of a material such as stainless steel.
- FIGS. 10 - 12 illustrate a preferred geometry for practicing the present invention, the technique for controlling length variations by varying the widths of selected portions of
Abstract
The present disclosure relates to a stent including a stent body having a stent axis. The stent body includes structural members defining openings through the stent body. The structural members are provided with regions having different widths. The relative sizes of the widths are selected to control the length of the stent body as the stent body is radially expanded from an un-deployed orientation to a deployed orientation. In one embodiment, the regions having different widths are provided by tapering the widths of selected segments of the structural member.
Description
- The present application is a continuation-in-part of co-pending and commonly assigned U.S. patent application Ser. No. 09/545,810 which is a continuation of commonly assigned U.S. patent application Ser. No. 09/049,486 filed Mar. 27, 1998, now U.S. Pat. No. 6,132,460.
- 1. Field of the Invention
- This invention pertains to stents for use in intraluminal applications. More particularly, this invention pertains to a novel structure for such stents.
- 2. Description of the Prior Art
- Stents are widely used for numerous applications where the stent is placed in the lumen of a patient and expanded. Such stents may be used in coronary or other vasculature, as well as other body lumens.
- Commonly, stents are cylindrical members. The stents expand from reduced diameters to enlarged diameters. Frequently, such stents are placed on a balloon catheter with the stent in the reduced-diameter state. So placed, the stent is advanced on the catheter to a placement site. At the site, the balloon is inflated to expand the stent to the enlarged diameter. The balloon is deflated and removed, leaving the enlarged diameter stent in place. So used, such stents are used to expand occluded sites within a patient's vasculature or other lumen.
- Examples of prior art stents are numerous. For example, U.S. Pat. No. 5,449,373 to Pinchasik et al. teaches a stent with at least two rigid segments joined by a flexible connector. U.S. Pat. No. 5,695,516 to Fischell teaches a stent with a cell having a butterfly shape when the stent is in a reduced-diameter state. Upon expansion of the stent, the cell assumes a hexagonal shape.
- In stent design, it is desirable for the stent to be flexible along its longitudinal axis to permit passage of the stent through arcuate segments of a patient's vasculature or other body lumen. Preferably, the stent will have at most minimal longitudinal shrinkage when expanded and will resist compressive forces once expanded.
- The present disclosure relates to a stent including a stent body having a stent axis. The stent body includes structural members that define openings through the stent body. The structural members are provided with regions having different widths. The relative sizes of the widths are selected to control the length of the stent body as the stent body is radially expanded from an un-deployed orientation to a deployed orientation. In one embodiment, the regions having different widths are provided by tapering the widths of selected segments of the structural member. In a preferred embodiment, the relative sizes of the widths are selected to minimize or eliminate length changes as the stent body is expanded from the un-deployed orientation to the expanded orientation.
- FIG. 1 is a perspective view of a first embodiment of a stent according to the present invention shown in a rest diameter state and showing a plurality of stent cells each having a major axis perpendicular to an axis of the stent;
- FIG. 2 is a plan view of the stent of FIG. 1 as it would appear if it were longitudinally split and laid out flat;
- FIG. 3 is the view of FIG. 2 following expansion of the stent to an enlarged diameter;
- FIG. 4 is a view taken along line4-4 in FIG. 2;
- FIG. 5 is a view taken along line5-5 in FIG. 2;
- FIG. 6 is an enlarged view of a portion of FIG. 2 illustrating a cell structure with material of the stent surrounding adjacent cells shown in phantom lines;
- FIG. 7 is the view of FIG. 2 showing an alternative embodiment of the present invention with a cell having five peaks per longitudinal segment;
- FIG. 8 is the view of FIG. 2 showing an alternative embodiment of the present invention with a major axis of the cell being parallel to an axis of the stent; and
- FIG. 9 is the view of FIG. 8 following expansion of the stent to an enlarged diameter;
- FIG. 10 is a plan view of another stent as it would appear if it were longitudinally split and laid out flat;
- FIG. 11 is an enlarged view of a portion of the stent of FIG. 10; and
- FIG. 12 is a plan view of a portion of the stent of FIG. 10 in a deployed/expanded orientation, the stent has been longitudinally cut and laid flat.
- Referring now to the several drawing figures in which identical elements are numbered identically, a description of the preferred embodiment of the present invention will now be provided. Where several embodiments are shown, common elements are similarly numbered and not separately described with the addition of apostrophes to distinguish the embodiments.
- FIG. 1 illustrates a
stent 10 having a rest length Lr and an un-deployed or reduced diameter Dr. For ease of illustration, thestent 10 is shown flat in FIG. 2 which illustrates a rest circumference Cr (Cr=πDr). In FIG. 2, locations A, B, C, D, E, F and G are shown severed from their normally integrally formed locations A1, B1, C1, D1, E1, F1 and G1. This permits thestent 10 to be shown as if it were severed at normally integrally formed locations A-Al, B-B1, C-C1, D-D1, E-El, F-F1 and G-G1 and laid flat. FIG. 6 is an enlarged portion of the view of FIG. 2 to better illustrate a novel cell structure as will be described. Thestent 10 is a reticulated, hollow tube. Thestent 10 may be expanded from the rest diameter Dr (and corresponding rest circumference Cr) to an expanded or enlarged diameter. FIG. 3 is a view similar to FIG. 2 (i.e., illustrating the expandedstent 10 as it would appear if longitudinally split and laid flat). Since FIG. 3 is a two-dimensional representation, the enlarged diameter is not shown. However, the enlarged circumference Ce is shown as well as a length Le following expansion. The expanded diameter is equal to Ce/π. - As will be discussed length Le is preferably not more than minimally smaller (e.g., less than 10% smaller) than length Lr. Ideally, Le equals Lr.
- The material of the
stent 10 defines a plurality ofcells 12. Thecells 12 are bounded areas which are open (i.e., extend through the wall thickness of the stent 10). Thestent 10 may be formed through any suitable means including laser or chemical milling. In such processes, a hollow cylindrical tube is milled to remove material and form theopen cells 12. - The
cells 12 have a longitudinal or major axis XM-XM and a transverse or minor axis Xm-Xm. In the embodiments of FIGS. 1-3, the major axis XM-XM is perpendicular to the longitudinal cylindrical axis X-X of thestent 10. In the embodiments of FIGS. 8 and 9, the major axis XM′-XM′ is parallel to the longitudinal cylindrical axis X′-X′ of thestent 10′. Thecell 12 is symmetrical about axes XM-XM and Xm-Xm. - The
cell 12 is defined by portions of the tube material including first and secondlongitudinal segments 14. Thesegments 14 each have a longitudinal axis Xa-Xa as shown in FIG. 6. The segments' longitudinal axes Xa-Xa are parallel to and positioned on opposite sides of the cell major axis XM-XM. - Each of
longitudinal segments 14 has an undulating pattern to define a plurality ofpeaks valleys peaks valleys - Each of the
peaks valleys peaks valleys straight segments straight end portions segments 14 are joined at first and secondlongitudinal connection locations 27 spaced apart on the major axis XM-XM. First and secondtransverse connection locations 28 are spaced apart on the minor axis Xm-Xm. The first and secondtransverse connection locations 28 are positioned at the apices of the center peaks 21 of thelongitudinal segments 14. - Except as will be described, the
segments 14 have uniform cross-sectional dimensions throughout their length as illustrated in FIG. 4. By way of non-limiting example, the width W and thickness T of thestraight line segments - For reasons that will be described, the width W′ (FIG. 5) at the apices of the
peaks valleys peaks valleys straight segments transverse connection locations - The combined lengths of segments16-20 to the apex of
peak 21 represent apath length 50 fromlongitudinal connection location 27 totransverse connection location 28. Similarly the combined lengths of the other arcuate and straight segments 22-26 to the apex ofpeak 21 represent identicallength path lengths 51 of identical geometry fromlongitudinal connection locations 27 totransverse connection locations 28. Each of thepath lengths longitudinal connection locations longitudinal connection locations stent 10 is expanded. Thepath lengths - The
stent 10 includes a plurality ofidentical cells 12. Opposite edges of thesegments 14 define obliquely adjacent cells (such ascells Cells 12 having major axes XM-XM collinear with the major axis XM-XM ofcell 12 are interconnected at thelongitudinal connection locations 27. Cells having minor axes collinear with the minor axis Xm-Xm ofcell 12 are interconnected at thetransverse connection locations 28. - As mentioned, the
stent 10 in the reduced diameter of FIG. 1 is advanced to a site in a lumen. Thestent 10 is then expanded at the site. Thestent 10 may be expanded through any conventional means. For example, thestent 10 in the reduced diameter may be placed on the balloon tip of a catheter. At the site, the balloon is expanded to generate radial forces on the interior of thestent 10. The radial forces urge thestent 10 to radially expand without appreciable longitudinal expansion or contraction. Plastic deformation of the material of the stent 10 (e.g., stainless steel) results in thestent 10 retaining the expanded shape following subsequent deflation of the balloon. Alternatively, thestent 10 may be formed of a super-elastic or shape memory material (such as nitinol—a well-known stent material which is an alloy of nickel and titanium). - As the
stent 10 expands, thepath lengths path lengths stent 10 has been only partially expanded to an expanded diameter less than a maximum expanded diameter. At a maximum expanded size, thepath lengths stent 10 beyond the maximum expanded size would result in narrowing of the minor axis Xm-Xm (i.e., a narrowing of a separation between the transverse connection locations and a resulting narrowing of the length Lr of the stent) or would require stretching and thinning of the stent material. - As shown in FIG. 3, during expansion of the
stent 10, thestraight segments path lengths arcuate peaks valleys peaks valleys straight segments arcuate peaks valleys straight segments - As the
stent 10 expands, thecells 12 assume a diamond shape shown in FIG. 3. Since the expansion forces are radial, the length of the major axis XM-XM (i.e., the distance between the longitudinal connection locations 27) increases. The length of the minor axis Xm-Xm (and hence the length of the stent 10) remains unchanged. - The
stent 10 is highly flexible. To advance to a site, the axis X-X of thestent 10 must bend to navigate through a curved lumen. Further, for placement at a curved site in a lumen, thestent 10 must be sufficiently flexible to retain a curved shape following expansion and to bend as the lumen bends over time. Thestent 10, as described above, achieves these objections. - When bending on its axis X-X, the
stent 10 tends to axially compress on the inside of the bend and axially expand on the outside of the bend. The present design permits such axial expansion and contraction. Thenovel cell geometry 12 results in an accordion-like structure which is highly flexible before and after radial expansion. Further, the diamond shape of thecells 12 after radial expansion resists constricting forces otherwise tending to collapse thestent 10. - Numerous modifications are possible. For example the
stent 10 may be lined with either an inner or outer sleeve (such as polyester fabric or ePTFE) for tissue growth. Also, the stent may be coated with radiopaque coatings such as platinum, gold, tungsten or tantalum. In addition to materials previously discussed, the stent may be formed of any one of a wide variety of previous known materials including, without limitation, MP35N, tantalum, platinum, gold, Elgiloy and Phynox. - While three
cells 12 are shown in FIG. 2 longitudinally connected surrounding the circumference Cr of the stent, a different number could be so connected to vary the properties of thestent 10 as a designer may elect. Likewise, while each column ofcells 12 in FIG. 2 is shown as having three longitudinally connectedcells 12, the number of longitudinally connectedcells 12 could vary to adjust the properties of the stent. Also, while eachlongitudinal segment 14 is shown as having threepeaks longitudinal segment 14, the number of peaks could vary. FIG. 7 illustrates astent 10″ with acell 12″ having fivepeaks 117″, 17″, 21″, 25″ and 125″ perlongitudinal segment 14″. Preferably, the longitudinal segment will have an odd number of peaks so that the transverse connection points are at an apex of a center peak. - FIGS. 8 and 9 illustrate an alternative embodiment where the major axis XM′-XM′ of the
cells 12′ are parallel with the cylindrical axis X′-X′ of thestent 10′. In FIG. 9, the expandedstent 10′ is shown at a near fully expanded state where thepath lengths 50′, 51′ are substantially linear. - When forming the stent from shape memory metal such as nitinol, the stent can be laser cut from a nitinol tube. Thereafter, the stent can be subjected to a shape-setting process in which the cut tube is expanded on a mandrel and then heated. Multiple expansion and heating cycles can be used to shape-set the stent to the final expanded diameter. Preferably, the final expanded diameter is equal to the desired deployed diameter of the stent. During expansion, the stent is preferably axially restrained such that the length of the stent does not change during expansion. The finished stent preferably has an austenite finish temperature less than body temperature. Thus, at body temperature, the stent will self-expand to the desired deployed diameter due to the shape memory characteristic of the metal forming the stent.
- In use, the finished stent can be mounted on a delivery catheter. As is conventionally known in the art, the stent can be held in a compressed orientation on the delivery catheter by a retractable sheath. As is also known in the art, the delivery catheter can be used to advance the stent to a deployment location (e.g., a constricted region of a vessel). At the deployment cite, the sheath is retracted thereby releasing the stent. Once released, the stent self-expands to the deployed diameter.
- It has been noted that the lengths of prior art stents when mounted on a delivery catheter can be different from the deployed lengths of such stents. For example, it has been determined that the deployed lengths of the prior art stents are often shorter than the compressed orientation lengths (i.e., the lengths of the stents when mounted on a delivery catheter). Shortening can be problematic because shortening makes it more difficult for a physician to accurately place a stent at a desired position in a vessel.
- An important aspect of the present invention relates to a stent design that reduces or eliminates shortening of a stent. For example, one embodiment of the present invention relates to a stent having the same length or substantially the same length at each of the following stages: 1) when the stent is initially cut from a tube of shape-memory alloy; 2) when the stent is shape-set to the desired expanded diameter; 3) when the stent is compressed on the delivery catheter; and 4) when the stent is deployed at a deployment location.
- With respect to shape memory stents, it has been found that varying the width of the
segments segments connection locations 27, and reduced widths adjacent theircorresponding peaks segments connection locations 28, and reduced widths adjacent their correspondingvalleys - FIGS.10-12 show a
stent 210 having a cell structure adapted to limit any length changes that may occur as the stent is expanded from the compressed orientation to the deployed orientation. Preferably the length change between the compressed orientation and the deployed orientation is less than 5 percent. More preferably, the length change between the compressed orientation and the deployed orientation is less than 2 percent. Most preferably, thestent 210 experiences substantially no length change as it is released from a delivery catheter and expanded from the compressed orientation to the deployed orientation. - FIG. 10 shows the
stent 210 cut longitudinally along its length and laid flat. Thestent 210 has a length L and a circumference C. FIG. 10 is representative of thestent 210 after thestent 210 has been laser cut from a shape-memory tube, but before thestent 210 has been shape-set to the expanded diameter. FIG. 12 shows a portion of thestent 210 after the stent has be shape-set to the desired expanded diameter. In both FIGS. 10 and 12, thestent 210 is elongated along axis A-A and includes a stent body (i.e., a three-dimensional structure) having cell defining portions that define plurality ofcells 212. After thestent 210 has been shape-set to the expanded diameter as shown in FIG. 12, thecells 212 are preferably more open than thecells 212 depicted in FIG. 10. However, while the circumference C increases, the length L preferably remains substantially the same at both diameters. - Referring to FIG. 11, the cell defining portions of the stent body include
circumferential connection locations 227 andlongitudinal connection locations 228. “Circumferential connection locations” are locations where circumferentially adjacent cell defining structures, as defined relative to axis A-A, are connected together. “Longitudinal connection locations” are locations where longitudinally adjacent cell defining portions, as define relative to the axis A-A, are connected together. - Referring still to FIG. 11, each cell defining portion includes two axially spaced-apart members214 (i.e., members that are spaced-apart from one another along the axis A-A) that extend circumferentially about the axis A-A in an undulating pattern. The
members 214 extend in the undulating pattern between thecircumferential connection locations 227. Adjacent thecircumferential connection locations 227, the ends of the undulatingmembers 214 are connected to one another. At thelongitudinal connection locations 228, the undulatingmembers 214 merge with the undulatingmembers 214 of longitudinally adjacent cell defining portions. - Still referring to FIG. 11, each undulating
member 214 is shown including: 1) asegment 226 that extends fromconnection location 227 to peak 225; 2) asegment 224 that extends frompeak 225 tovalley 223; 3) asegment 222 that extends fromvalley 223 toconnection location 228; 4) asegment 220 that extends fromconnection location 228 tovalley 219; 5) asegment 218 that extends fromvalley 219 to peak 217; and 6) asegment 216 that extends frompeak 217 toconnection location 227. The segments 216-226 preferably extend generally longitudinally along thestent 210. The term “generally longitudinally” will be understood to mean that the segments 216-226 are closer to a parallel relationship relative to the axis A-A of thestent 210 than to a transverse relationship relative to the axis A-A of thestent 210. - To prevent length changes during deployment of the stent, the
segments connection locations 227, and reduced widths W2 adjacent theircorresponding peaks segments connection locations 228, and reduced widths W2 adjacent their correspondingvalleys segments - Referring once again to FIG. 11, pairs of tapered
segments circumferential connection location 227, and pairs of taperedsegments longitudinal connection location 228. Each pair of tapered segments is defined by aninner cut 250 that is parallel to the axis A-A of thestent 210, and twoouter cuts 252 that are angled relative to the axis A-A of thestent 210. Preferably, theouter cuts 252 diverge from one another as thecuts 252 extend toward theircorresponding connection location cuts 252 causes thesegments segments cuts 252 causes thesegments stent 210. - The narrowing from width W1 to W2 results in a taper along the lengths of the
segments stent 210. More preferably, the taper angle B is in the range of 1-3 percent. It has been found that the relative sizes of W1 and W2 have an effect on the deployed length of the stent 210 (i.e., the length of the stent after deployment in a vessel) as compared to the compressed length of the stent 210 (i.e., the length of the stent when mounted on a delivery catheter). As a result, in the design of the stent, the widths W1 and W2 can be selected to effect a desired change in length including no change in length if so desired. For example, a stent having a 5 millimeter cell length Lc (labeled on FIG. 11), a first width W1 of 0.0065 inch and a second width W2 of 0.0059 inch, has been found to lengthen about 10% during expansion from the compressed orientation to the deployed orientation. Alternatively, a stent having a 5 millimeter cell length Lc (labeled on FIG. 11), a first width W1 of 0.009 and a second width W2 of 0.0047, has been found to shorten about 10% during expansion from the compressed orientation to the deployed orientation. Further, a stent with a 5 millimeter cell length Lc (labeled on FIG. 11), a first width W1 of 0.008 inches, a second width W2 of 0.0052 inches and an angle B of two degrees has been found to experience no lengthening and no shortening when expanded from the compressed orientation and the deployed orientation. - While a preferred use for the inventive features disclosed in FIGS.10-12 is in a self-expanding stent, the features also have benefits when used with non-self-expanding stents (e.g., balloon expandable stents made of a material such as stainless steel). Also, while FIGS. 10-12 illustrate a preferred geometry for practicing the present invention, the technique for controlling length variations by varying the widths of selected portions of a stent is also applicable to stents having other geometries, shapes, or strut patterns. Further, the various aspects of the present invention can also be used to cause a desired shortening or lengthening of a stent during deployment.
- From the foregoing, the present invention has been shown in a preferred embodiment. Modifications and equivalents are intended to be included within the scope of the appended claims.
Claims (31)
1. A stent comprising:
a stent body having a stent axis;
the stent body including a structural member extending in an undulating pattern about a circumference of the stent body;
the structural member including a plurality of segments that extend generally longitudinally along the stent axis; and
at least some of the segments having widths that taper as the at least some segments extend longitudinally along the stent axis.
2. The stent of claim 1 , wherein a taper angle of the widths is selected to minimize a length change of the stent body as the stent body is radially expanded from an un-deployed orientation to a deployed orientation.
3. The stent of claim 1 , wherein the at least some segments include pairs of tapered segments, the pairs of tapered segments being interconnected by non-tapered segments.
4. The stent of claim 3 , wherein the non-tapered segments are skewed relative to the stent axis.
5. The stent of claim 1 , wherein the segments are substantially straight.
6. The stent of claim 1 , wherein the stent body is made of a shape-memory metal.
7. A stent comprising:
a stent body having a stent axis;
the stent body including a plurality of cell structures defining a plurality of cells;
the cell structures including structural members that extend in an undulating pattern about a circumference of the stent body;
the structural members including segments that extend generally longitudinally along the stent axis;
the structural members including peaks and valleys;
the cell structures being interconnected at connection locations;
at least some of the segments extending from the connection locations to the peaks and valleys; and
the at least some segments having enlarged first widths adjacent the connection locations as compared to smaller second widths located adjacent the peaks and valleys.
8. The stent of claim 7 , wherein the at least some of the segments are provided with a narrowing width taper that extends between the first and second widths.
9. The stent of claim 7 , wherein the relative sizes of the first and second widths are selected to minimize a length change of the stent body as the stent body is radially expanded from an un-deployed orientation to a deployed orientation.
10. The stent of claim 7 , wherein the at least some segments include pairs of tapered segments positioned at the connection locations, the pairs of tapered segments being interconnected by non-tapered segments.
11. The stent of claim 10 , wherein the non-tapered segments are skewed relative to the stent axis.
12. The stent of claim 7 , wherein the segments are straight.
13. The stent of claim 7 , wherein the connection locations include longitudinal connection locations and circumferential connection locations.
14. The stent of claim 13 , wherein the cells are symmetrical about first axes extending through the circumferential connection locations, and the cells are also symmetrical about second axes extending through the longitudinal connection locations.
15. A stent comprising:
a stent body having a stent axis;
the stent body including a structural member extending in an undulating pattern about a circumference of the stent body;
the structural member including peaks and valleys, and also including segments that interconnect the peaks and valleys; and
at least some of the segments having widths that taper along lengths of the at least some segments.
16. The stent of claim 15 , wherein the segments are substantially straight.
17. The stent of claim 15 , wherein the structural members form cell structures that are interconnected at connection locations, and wherein the at least some segments have larger widths adjacent the connection locations than adjacent the peaks and valleys.
18. The stent of claim 15 , wherein a taper angle of the widths is selected to control a length change of the stent body as the stent body is radially expanded from an un-deployed orientation to a deployed orientation.
19. The stent of claim 18 , wherein the taper angle is selected to minimize a length change of the stent body as the stent body is expanded from the un-deployed orientation to the deployed orientation.
20. A stent comprising:
a stent body having a stent axis, the stent body being radially expandable from a non-deployed orientation having a first length to a deployed orientation having a second length;
the stent body including a structural member extending in an undulating pattern about a circumference of the stent body; and
the first length being substantially equal to the second length.
21. A method for making a stent, the method comprising:
constructing a stent body having a stent axis, the stent body including structural members defining openings through the stent body; and
during construction of the stent body, providing at least some of the structural members with regions having first and second different widths, the relative sizes of the first and second widths being selected to control a length of the stent body as the stent body is radially expanded from an un-deployed orientation to a deployed orientation.
22. The method of claim 21 , wherein the relative sizes of the widths are selected to minimize a length variation when the stent body is radially expanded from the un-deployed orientation to the deployed orientation.
23. The method of claim 21 , further comprising providing the structural members with a gradual taper in width between the first and second widths.
24. The method of claim 23 , wherein the segments are substantially straight.
25. The method of claim 21 , further comprising shape-setting the stent body to an expanded diameter corresponding to the deployed orientation after the stent body has been constructed.
26. The method of claim 21 , wherein the structural members extend in undulating patterns.
27. A stent comprising:
a stent body that is radially expandable from an un-deployed orientation to a deployed orientation;
the stent body including structural members defining openings through the stent body;
the structural members including segments having first regions with enlarged widths and second regions with more narrow widths; and
the relative sizes of the enlarged widths and the more narrow widths are selected to control a length of the stent body as the stent body is expanded from the un-deployed orientation to the deployed orientation.
28. The stent of claim 27 , wherein the relative sizes of widths are selected to minimize a change in the length of the stent body as the stent body is expanded from the un-deployed orientation to the deployed orientation.
29. The stent of claim 27 , wherein widths of the segments gradually taper between the enlarged widths and the more narrow widths.
30. The stent of claim 29 , wherein the segments are substantially straight between the first regions and the second regions.
31. The stent of claim 30 , wherein between the first and second regions, the segments extend in a generally longitudinal direction relative to an axis of the stent.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/389,273 US20030229391A1 (en) | 1998-03-27 | 2003-08-14 | Stent |
US11/533,591 US20070088429A1 (en) | 1998-03-27 | 2006-09-20 | Stent with dual support structure |
US12/611,114 US9034029B2 (en) | 1998-03-27 | 2009-11-02 | Stents with tapered struts |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/049,486 US6132460A (en) | 1998-03-27 | 1998-03-27 | Stent |
US09/545,810 US6358274B1 (en) | 1998-03-27 | 2000-04-07 | Stent |
US09/765,725 US6558415B2 (en) | 1998-03-27 | 2001-01-18 | Stent |
US10/389,273 US20030229391A1 (en) | 1998-03-27 | 2003-08-14 | Stent |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/765,725 Continuation US6558415B2 (en) | 1998-03-27 | 2001-01-18 | Stent |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/533,591 Continuation US20070088429A1 (en) | 1998-03-27 | 2006-09-20 | Stent with dual support structure |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030229391A1 true US20030229391A1 (en) | 2003-12-11 |
Family
ID=25074316
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/765,725 Expired - Lifetime US6558415B2 (en) | 1998-03-27 | 2001-01-18 | Stent |
US10/389,273 Abandoned US20030229391A1 (en) | 1998-03-27 | 2003-08-14 | Stent |
US11/533,591 Abandoned US20070088429A1 (en) | 1998-03-27 | 2006-09-20 | Stent with dual support structure |
US12/611,114 Expired - Fee Related US9034029B2 (en) | 1998-03-27 | 2009-11-02 | Stents with tapered struts |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/765,725 Expired - Lifetime US6558415B2 (en) | 1998-03-27 | 2001-01-18 | Stent |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/533,591 Abandoned US20070088429A1 (en) | 1998-03-27 | 2006-09-20 | Stent with dual support structure |
US12/611,114 Expired - Fee Related US9034029B2 (en) | 1998-03-27 | 2009-11-02 | Stents with tapered struts |
Country Status (5)
Country | Link |
---|---|
US (4) | US6558415B2 (en) |
EP (3) | EP2298240A3 (en) |
AU (1) | AU2002237877A1 (en) |
ES (1) | ES2513065T3 (en) |
WO (1) | WO2002056795A2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090041978A1 (en) * | 2007-02-05 | 2009-02-12 | Sogard David J | Synthetic composite structures |
US20110208294A1 (en) * | 2006-10-20 | 2011-08-25 | Orbusneich Medical, Inc. | Bioabsorbable medical device with coating |
USD723165S1 (en) | 2013-03-12 | 2015-02-24 | C. R. Bard, Inc. | Stent |
US9066825B2 (en) | 2012-05-14 | 2015-06-30 | C.R. Bard, Inc. | Uniformly expandable stent |
US9173973B2 (en) | 2006-07-20 | 2015-11-03 | G. Lawrence Thatcher | Bioabsorbable polymeric composition for a medical device |
US20170007400A1 (en) * | 2007-02-05 | 2017-01-12 | Boston Scientific Scimed, Inc. | Synthetic composite structures |
US9724864B2 (en) | 2006-10-20 | 2017-08-08 | Orbusneich Medical, Inc. | Bioabsorbable polymeric composition and medical device |
Families Citing this family (120)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7204848B1 (en) | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
EP0884029B1 (en) * | 1997-06-13 | 2004-12-22 | Gary J. Becker | Expandable intraluminal endoprosthesis |
US6395019B2 (en) | 1998-02-09 | 2002-05-28 | Trivascular, Inc. | Endovascular graft |
JP4351388B2 (en) * | 1998-03-04 | 2009-10-28 | ボストン サイエンティフィック リミテッド | Improved stent cell structure |
EP1065993B1 (en) * | 1998-03-05 | 2010-08-11 | Boston Scientific Limited | Intraluminal stent |
US6558415B2 (en) * | 1998-03-27 | 2003-05-06 | Intratherapeutics, Inc. | Stent |
US6132461A (en) * | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent with dual support structure |
US6755856B2 (en) | 1998-09-05 | 2004-06-29 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation |
US7887578B2 (en) | 1998-09-05 | 2011-02-15 | Abbott Laboratories Vascular Enterprises Limited | Stent having an expandable web structure |
US7815763B2 (en) | 2001-09-28 | 2010-10-19 | Abbott Laboratories Vascular Enterprises Limited | Porous membranes for medical implants and methods of manufacture |
US6682554B2 (en) | 1998-09-05 | 2004-01-27 | Jomed Gmbh | Methods and apparatus for a stent having an expandable web structure |
US6273911B1 (en) | 1999-04-22 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Variable strength stent |
EP1132058A1 (en) * | 2000-03-06 | 2001-09-12 | Advanced Laser Applications Holding S.A. | Intravascular prothesis |
US8038708B2 (en) | 2001-02-05 | 2011-10-18 | Cook Medical Technologies Llc | Implantable device with remodelable material and covering material |
WO2002067782A2 (en) | 2001-02-26 | 2002-09-06 | Ev3 Peripheral, Inc. | Implant delivery system with interlock |
US6749628B1 (en) | 2001-05-17 | 2004-06-15 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US20040186551A1 (en) | 2003-01-17 | 2004-09-23 | Xtent, Inc. | Multiple independent nested stent structures and methods for their preparation and deployment |
US7137993B2 (en) | 2001-12-03 | 2006-11-21 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7351255B2 (en) | 2001-12-03 | 2008-04-01 | Xtent, Inc. | Stent delivery apparatus and method |
US7147656B2 (en) | 2001-12-03 | 2006-12-12 | Xtent, Inc. | Apparatus and methods for delivery of braided prostheses |
US7892273B2 (en) | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Custom length stent apparatus |
US7147661B2 (en) | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Radially expandable stent |
US6964681B2 (en) * | 2002-01-29 | 2005-11-15 | Medtronic Vascular, Inc. | Flared stent and method of use |
WO2003092549A2 (en) * | 2002-05-06 | 2003-11-13 | Abbott Laboratories | Endoprosthesis for controlled contraction and expansion |
WO2003094798A1 (en) * | 2002-05-08 | 2003-11-20 | Abbott Laboratories | Endoprosthesis having foot extensions |
US7025777B2 (en) † | 2002-07-31 | 2006-04-11 | Unison Therapeutics, Inc. | Flexible and conformable stent and method of forming same |
US20040054398A1 (en) * | 2002-09-13 | 2004-03-18 | Cully Edward H. | Stent device with multiple helix construction |
US7331986B2 (en) | 2002-10-09 | 2008-02-19 | Boston Scientific Scimed, Inc. | Intraluminal medical device having improved visibility |
US8105373B2 (en) | 2002-12-16 | 2012-01-31 | Boston Scientific Scimed, Inc. | Flexible stent with improved axial strength |
US7316710B1 (en) * | 2002-12-30 | 2008-01-08 | Advanced Cardiovascular Systems, Inc. | Flexible stent |
US7771463B2 (en) | 2003-03-26 | 2010-08-10 | Ton Dai T | Twist-down implant delivery technologies |
US8016869B2 (en) | 2003-03-26 | 2011-09-13 | Biosensors International Group, Ltd. | Guidewire-less stent delivery methods |
WO2004087006A2 (en) * | 2003-03-26 | 2004-10-14 | Cardiomind, Inc. | Implant delivery technologies |
US7717952B2 (en) * | 2003-04-24 | 2010-05-18 | Cook Incorporated | Artificial prostheses with preferred geometries |
US7625399B2 (en) * | 2003-04-24 | 2009-12-01 | Cook Incorporated | Intralumenally-implantable frames |
US7658759B2 (en) * | 2003-04-24 | 2010-02-09 | Cook Incorporated | Intralumenally implantable frames |
JP4940388B2 (en) * | 2003-04-24 | 2012-05-30 | クック メディカル テクノロジーズ エルエルシー | Prosthetic valve prosthesis with improved hydrodynamic properties |
US7625398B2 (en) * | 2003-05-06 | 2009-12-01 | Abbott Laboratories | Endoprosthesis having foot extensions |
US7625401B2 (en) * | 2003-05-06 | 2009-12-01 | Abbott Laboratories | Endoprosthesis having foot extensions |
US7235093B2 (en) * | 2003-05-20 | 2007-06-26 | Boston Scientific Scimed, Inc. | Mechanism to improve stent securement |
US8021418B2 (en) * | 2003-06-19 | 2011-09-20 | Boston Scientific Scimed, Inc. | Sandwiched radiopaque marker on covered stent |
US7131993B2 (en) * | 2003-06-25 | 2006-11-07 | Boston Scientific Scimed, Inc. | Varying circumferential spanned connectors in a stent |
US7090694B1 (en) * | 2003-11-19 | 2006-08-15 | Advanced Cardiovascular Systems, Inc. | Portal design for stent for treating bifurcated vessels |
US7326236B2 (en) | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
US7803178B2 (en) | 2004-01-30 | 2010-09-28 | Trivascular, Inc. | Inflatable porous implants and methods for drug delivery |
GB0402103D0 (en) * | 2004-02-02 | 2004-03-03 | Hengelmolen Rudy | Tubular graft |
US20050182474A1 (en) * | 2004-02-13 | 2005-08-18 | Medtronic Vascular, Inc. | Coated stent having protruding crowns and elongated struts |
US7651521B2 (en) | 2004-03-02 | 2010-01-26 | Cardiomind, Inc. | Corewire actuated delivery system with fixed distal stent-carrying extension |
US7323006B2 (en) | 2004-03-30 | 2008-01-29 | Xtent, Inc. | Rapid exchange interventional devices and methods |
US20050288766A1 (en) * | 2004-06-28 | 2005-12-29 | Xtent, Inc. | Devices and methods for controlling expandable prostheses during deployment |
US8317859B2 (en) | 2004-06-28 | 2012-11-27 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US20140114394A1 (en) * | 2004-07-26 | 2014-04-24 | Abbott Cardiovascular Systems Inc. | Biodegradable stent with enhanced fracture toughness |
US7731890B2 (en) * | 2006-06-15 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Methods of fabricating stents with enhanced fracture toughness |
US20140107761A1 (en) * | 2004-07-26 | 2014-04-17 | Abbott Cardiovascular Systems Inc. | Biodegradable stent with enhanced fracture toughness |
EP1804721A2 (en) * | 2004-10-14 | 2007-07-11 | Cardiomind, Inc. | Small vessel stent designs |
AU2005313947B2 (en) * | 2004-12-09 | 2010-09-23 | Cook Medical Technologies Llc | Variable curvature stent |
US20070073379A1 (en) * | 2005-09-29 | 2007-03-29 | Chang Jean C | Stent delivery system |
EP1895938B1 (en) | 2005-06-30 | 2019-02-20 | Abbott Laboratories | Endoprosthesis having foot extensions |
US7473272B2 (en) * | 2005-08-17 | 2009-01-06 | Medtronic Vascular, Inc. | Recapturable stent with minimum crossing profile |
US20070100414A1 (en) | 2005-11-02 | 2007-05-03 | Cardiomind, Inc. | Indirect-release electrolytic implant delivery systems |
CA2646885A1 (en) | 2006-03-20 | 2007-09-27 | Xtent, Inc. | Apparatus and methods for deployment of linked prosthetic segments |
US8211114B2 (en) | 2006-04-24 | 2012-07-03 | Ethicon Endo-Surgery, Inc. | Medical instrument having a medical snare |
US9138250B2 (en) | 2006-04-24 | 2015-09-22 | Ethicon Endo-Surgery, Inc. | Medical instrument handle and medical instrument having a handle |
US7837620B2 (en) * | 2006-04-25 | 2010-11-23 | Ethicon Endo-Surgery, Inc. | Medical tubular assembly |
US7927327B2 (en) * | 2006-04-25 | 2011-04-19 | Ethicon Endo-Surgery, Inc. | Medical instrument having an articulatable end effector |
US7959642B2 (en) | 2006-05-16 | 2011-06-14 | Ethicon Endo-Surgery, Inc. | Medical instrument having a needle knife |
US7892166B2 (en) * | 2006-05-18 | 2011-02-22 | Ethicon Endo-Surgery, Inc. | Medical instrument including a catheter having a catheter stiffener and method for using |
EP2035055A2 (en) | 2006-06-30 | 2009-03-18 | Ev3 Endovascular, Inc. | Medical devices with amorphous metals and methods therefor |
US8029558B2 (en) | 2006-07-07 | 2011-10-04 | Abbott Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US8834554B2 (en) * | 2006-08-22 | 2014-09-16 | Abbott Cardiovascular Systems Inc. | Intravascular stent |
US8882826B2 (en) * | 2006-08-22 | 2014-11-11 | Abbott Cardiovascular Systems Inc. | Intravascular stent |
US8414637B2 (en) * | 2006-09-08 | 2013-04-09 | Boston Scientific Scimed, Inc. | Stent |
US7988720B2 (en) | 2006-09-12 | 2011-08-02 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US9622888B2 (en) | 2006-11-16 | 2017-04-18 | W. L. Gore & Associates, Inc. | Stent having flexibly connected adjacent stent elements |
US10188534B2 (en) * | 2006-11-17 | 2019-01-29 | Covidien Lp | Stent having reduced passage of emboli and stent delivery system |
US20080199510A1 (en) | 2007-02-20 | 2008-08-21 | Xtent, Inc. | Thermo-mechanically controlled implants and methods of use |
US8486132B2 (en) | 2007-03-22 | 2013-07-16 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
EP2144580B1 (en) | 2007-04-09 | 2015-08-12 | Covidien LP | Stent delivery system |
US7810223B2 (en) | 2007-05-16 | 2010-10-12 | Boston Scientific Scimed, Inc. | Method of attaching radiopaque markers to intraluminal medical devices, and devices formed using the same |
US8016874B2 (en) | 2007-05-23 | 2011-09-13 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with elevated scaffolding properties |
US8128679B2 (en) | 2007-05-23 | 2012-03-06 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with torque-absorbing connectors |
US8226701B2 (en) | 2007-09-26 | 2012-07-24 | Trivascular, Inc. | Stent and delivery system for deployment thereof |
US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
US8663309B2 (en) | 2007-09-26 | 2014-03-04 | Trivascular, Inc. | Asymmetric stent apparatus and method |
EP2194921B1 (en) | 2007-10-04 | 2018-08-29 | TriVascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
US8083789B2 (en) | 2007-11-16 | 2011-12-27 | Trivascular, Inc. | Securement assembly and method for expandable endovascular device |
US8328861B2 (en) | 2007-11-16 | 2012-12-11 | Trivascular, Inc. | Delivery system and method for bifurcated graft |
US7850726B2 (en) * | 2007-12-20 | 2010-12-14 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having struts linked by foot extensions |
US8337544B2 (en) | 2007-12-20 | 2012-12-25 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having flexible connectors |
US8920488B2 (en) | 2007-12-20 | 2014-12-30 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having a stable architecture |
US8926688B2 (en) | 2008-01-11 | 2015-01-06 | W. L. Gore & Assoc. Inc. | Stent having adjacent elements connected by flexible webs |
US9101503B2 (en) * | 2008-03-06 | 2015-08-11 | J.W. Medical Systems Ltd. | Apparatus having variable strut length and methods of use |
US20160000553A1 (en) * | 2009-03-06 | 2016-01-07 | The Regents Of The University Of California | Thin film vascular stent for arterial disease |
US8657870B2 (en) | 2009-06-26 | 2014-02-25 | Biosensors International Group, Ltd. | Implant delivery apparatus and methods with electrolytic release |
US20110004294A1 (en) * | 2009-07-02 | 2011-01-06 | Abbott Laboratories | Fatigue-resistant stent |
EP2658484A1 (en) | 2010-12-30 | 2013-11-06 | Boston Scientific Scimed, Inc. | Multi stage opening stent designs |
DE102011009372B3 (en) * | 2011-01-25 | 2012-07-12 | Acandis Gmbh & Co. Kg | Medical device with a grid structure and a treatment system with such a grid structure |
WO2012119037A1 (en) | 2011-03-03 | 2012-09-07 | Boston Scientific Scimed, Inc. | Stent with reduced profile |
CA2823535A1 (en) | 2011-03-03 | 2012-09-07 | Boston Scientific Scimed, Inc. | Low strain high strength stent |
US9028540B2 (en) * | 2011-03-25 | 2015-05-12 | Covidien Lp | Vascular stent with improved vessel wall apposition |
US20130085564A1 (en) * | 2011-10-03 | 2013-04-04 | Abbott Cardiovascular Systems Inc. | Modified scaffolds for peripheral applications |
US10028854B2 (en) | 2012-02-02 | 2018-07-24 | Covidien Lp | Stent retaining systems |
US10940167B2 (en) | 2012-02-10 | 2021-03-09 | Cvdevices, Llc | Methods and uses of biological tissues for various stent and other medical applications |
US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
US9498363B2 (en) | 2012-04-06 | 2016-11-22 | Trivascular, Inc. | Delivery catheter for endovascular device |
US9254205B2 (en) | 2012-09-27 | 2016-02-09 | Covidien Lp | Vascular stent with improved vessel wall apposition |
US20140142693A1 (en) * | 2012-11-20 | 2014-05-22 | Medtronic, Inc | Valve Prosthesis Frames |
US10617517B2 (en) * | 2013-01-14 | 2020-04-14 | Medtronic CV Luxembourg S.a.r.l. | Valve prosthesis frames |
AU2014214700B2 (en) | 2013-02-11 | 2018-01-18 | Cook Medical Technologies Llc | Expandable support frame and medical device |
US9180031B2 (en) | 2013-03-15 | 2015-11-10 | Covidien Lp | Stent with varying radius between struts |
US9259335B2 (en) | 2013-03-15 | 2016-02-16 | Covidien Lp | Stent |
US9907684B2 (en) | 2013-05-08 | 2018-03-06 | Aneuclose Llc | Method of radially-asymmetric stent expansion |
US10299948B2 (en) | 2014-11-26 | 2019-05-28 | W. L. Gore & Associates, Inc. | Balloon expandable endoprosthesis |
US10568752B2 (en) | 2016-05-25 | 2020-02-25 | W. L. Gore & Associates, Inc. | Controlled endoprosthesis balloon expansion |
US20180055669A1 (en) * | 2016-09-01 | 2018-03-01 | Veinovo, LLC | Luminal implant for the correction of occlusions |
US10905572B2 (en) * | 2016-11-14 | 2021-02-02 | Covidien Lp | Stent |
US10258488B2 (en) | 2016-11-14 | 2019-04-16 | Covidien Lp | Stent |
US10449069B2 (en) | 2016-11-14 | 2019-10-22 | Covidien Lp | Stent |
US10568696B2 (en) | 2017-07-17 | 2020-02-25 | International Business Machines Corporation | Apparatus for supporting personalized coronary stents |
WO2022245435A1 (en) * | 2021-05-20 | 2022-11-24 | Cook Medical Technologies Llc | Self expanding stent and method of loading same into a catheter |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5733303A (en) * | 1994-03-17 | 1998-03-31 | Medinol Ltd. | Flexible expandable stent |
US6423090B1 (en) * | 2000-02-11 | 2002-07-23 | Advanced Cardiovascular Systems, Inc. | Stent pattern with staged expansion |
US6520985B1 (en) * | 1998-03-27 | 2003-02-18 | Cordis Corporation | Stent with reduced shortening |
US6540774B1 (en) * | 1999-08-31 | 2003-04-01 | Advanced Cardiovascular Systems, Inc. | Stent design with end rings having enhanced strength and radiopacity |
Family Cites Families (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU86084A1 (en) * | 1985-09-20 | 1987-04-02 | Faco Sa | ELECTRIC MASSAGE APPARATUS |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
EP0556940A1 (en) | 1986-02-24 | 1993-08-25 | Robert E. Fischell | Intravascular stent |
CA1322628C (en) | 1988-10-04 | 1993-10-05 | Richard A. Schatz | Expandable intraluminal graft |
US5019085A (en) | 1988-10-25 | 1991-05-28 | Cordis Corporation | Apparatus and method for placement of a stent within a subject vessel |
US4913141A (en) | 1988-10-25 | 1990-04-03 | Cordis Corporation | Apparatus and method for placement of a stent within a subject vessel |
CH678393A5 (en) | 1989-01-26 | 1991-09-13 | Ulrich Prof Dr Med Sigwart | |
DE9010130U1 (en) | 1989-07-13 | 1990-09-13 | American Medical Systems, Inc., Minnetonka, Minn., Us | |
US5019665A (en) * | 1990-04-18 | 1991-05-28 | Mobil Oil Corp. | Shape-selective process for concentrating diamondoid-containing hydrocarbon solvents |
US5591172A (en) | 1991-06-14 | 1997-01-07 | Ams Medinvent S.A. | Transluminal implantation device |
CA2380683C (en) | 1991-10-28 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5540712A (en) | 1992-05-01 | 1996-07-30 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
US5817102A (en) | 1992-05-08 | 1998-10-06 | Schneider (Usa) Inc. | Apparatus for delivering and deploying a stent |
US5342348A (en) | 1992-12-04 | 1994-08-30 | Kaplan Aaron V | Method and device for treating and enlarging body lumens |
US5419760A (en) | 1993-01-08 | 1995-05-30 | Pdt Systems, Inc. | Medicament dispensing stent for prevention of restenosis of a blood vessel |
DE4303181A1 (en) | 1993-02-04 | 1994-08-11 | Angiomed Ag | Implantable catheter |
JP2703510B2 (en) | 1993-12-28 | 1998-01-26 | アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド | Expandable stent and method of manufacturing the same |
US5449373A (en) | 1994-03-17 | 1995-09-12 | Medinol Ltd. | Articulated stent |
DE69532049T2 (en) | 1994-04-01 | 2004-07-08 | Prograft Medical, Inc., Palo Alto | Self-expanding stent or stent graft and method for its preparation |
EP0679372B1 (en) | 1994-04-25 | 1999-07-28 | Advanced Cardiovascular Systems, Inc. | Radiopaque stent markers |
US5476508A (en) | 1994-05-26 | 1995-12-19 | Tfx Medical | Stent with mutually interlocking filaments |
US5649977A (en) | 1994-09-22 | 1997-07-22 | Advanced Cardiovascular Systems, Inc. | Metal reinforced polymer stent |
JP3130318B2 (en) | 1994-10-27 | 2001-01-31 | シュナイダー(ユーエスエー)インク | Stent delivery device |
IL115756A0 (en) | 1994-10-27 | 1996-01-19 | Medinol Ltd | Stent fabrication method |
US5591197A (en) | 1995-03-14 | 1997-01-07 | Advanced Cardiovascular Systems, Inc. | Expandable stent forming projecting barbs and method for deploying |
CA2171896C (en) | 1995-03-17 | 2007-05-15 | Scott C. Anderson | Multi-anchor stent |
US5728131A (en) | 1995-06-12 | 1998-03-17 | Endotex Interventional Systems, Inc. | Coupling device and method of use |
DK171865B1 (en) | 1995-09-11 | 1997-07-21 | Cook William Europ | Expandable endovascular stent |
US6287336B1 (en) * | 1995-10-16 | 2001-09-11 | Medtronic, Inc. | Variable flexibility stent |
US6203569B1 (en) * | 1996-01-04 | 2001-03-20 | Bandula Wijay | Flexible stent |
US5895406A (en) * | 1996-01-26 | 1999-04-20 | Cordis Corporation | Axially flexible stent |
JPH09215753A (en) | 1996-02-08 | 1997-08-19 | Schneider Usa Inc | Self-expanding stent made of titanium alloy |
US5843117A (en) * | 1996-02-14 | 1998-12-01 | Inflow Dynamics Inc. | Implantable vascular and endoluminal stents and process of fabricating the same |
US5695516A (en) | 1996-02-21 | 1997-12-09 | Iso Stent, Inc. | Longitudinally elongating balloon expandable stent |
US5707387A (en) | 1996-03-25 | 1998-01-13 | Wijay; Bandula | Flexible stent |
DE19614160A1 (en) | 1996-04-10 | 1997-10-16 | Variomed Ag | Stent for transluminal implantation in hollow organs |
US5697971A (en) | 1996-06-11 | 1997-12-16 | Fischell; Robert E. | Multi-cell stent with cells having differing characteristics |
US6077295A (en) | 1996-07-15 | 2000-06-20 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent delivery system |
US5807404A (en) * | 1996-09-19 | 1998-09-15 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US5810872A (en) | 1997-03-14 | 1998-09-22 | Kanesaka; Nozomu | Flexible stent |
US5853419A (en) | 1997-03-17 | 1998-12-29 | Surface Genesis, Inc. | Stent |
US5718713A (en) | 1997-04-10 | 1998-02-17 | Global Therapeutics, Inc. | Surgical stent having a streamlined contour |
DE19717475C1 (en) * | 1997-04-25 | 1998-09-03 | Heraeus Gmbh W C | Radially expandable support structure or stent for tubular vessel in body |
US6451049B2 (en) * | 1998-04-29 | 2002-09-17 | Sorin Biomedica Cardio, S.P.A. | Stents for angioplasty |
US5741327A (en) | 1997-05-06 | 1998-04-21 | Global Therapeutics, Inc. | Surgical stent featuring radiopaque markers |
DE19722384A1 (en) | 1997-05-28 | 1998-12-03 | Gfe Ges Fuer Forschung Und Ent | Flexible expandable stent |
FR2764794B1 (en) | 1997-06-20 | 1999-11-12 | Nycomed Lab Sa | EXPANDED TUBULAR DEVICE WITH VARIABLE THICKNESS |
CA2241558A1 (en) * | 1997-06-24 | 1998-12-24 | Advanced Cardiovascular Systems, Inc. | Stent with reinforced struts and bimodal deployment |
US5855600A (en) * | 1997-08-01 | 1999-01-05 | Inflow Dynamics Inc. | Flexible implantable stent with composite design |
US6206910B1 (en) * | 1997-09-11 | 2001-03-27 | Wake Forest University | Compliant intraluminal stents |
JP4292710B2 (en) * | 1997-09-24 | 2009-07-08 | エム イー ディ インスチィチュート インク | Radially expandable stent |
US6042606A (en) * | 1997-09-29 | 2000-03-28 | Cook Incorporated | Radially expandable non-axially contracting surgical stent |
DE19746882A1 (en) | 1997-10-23 | 1999-04-29 | Angiomed Ag | Expandable stent for tubular anatomical structures such as bile-ducts |
US6309414B1 (en) * | 1997-11-04 | 2001-10-30 | Sorin Biomedica Cardio S.P.A. | Angioplasty stents |
US6190406B1 (en) * | 1998-01-09 | 2001-02-20 | Nitinal Development Corporation | Intravascular stent having tapered struts |
EP1052950A1 (en) | 1998-02-03 | 2000-11-22 | B. Braun Celsa | Prosthesis with undulating longitudinal braces |
US5938697A (en) * | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
US6132460A (en) | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent |
US6558415B2 (en) * | 1998-03-27 | 2003-05-06 | Intratherapeutics, Inc. | Stent |
US6132461A (en) | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent with dual support structure |
US6120522A (en) | 1998-08-27 | 2000-09-19 | Scimed Life Systems, Inc. | Self-expanding stent delivery catheter |
US6193744B1 (en) * | 1998-09-10 | 2001-02-27 | Scimed Life Systems, Inc. | Stent configurations |
US6083259A (en) * | 1998-11-16 | 2000-07-04 | Frantzen; John J. | Axially non-contracting flexible radially expandable stent |
US6325825B1 (en) * | 1999-04-08 | 2001-12-04 | Cordis Corporation | Stent with variable wall thickness |
US6273911B1 (en) * | 1999-04-22 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Variable strength stent |
US6312459B1 (en) * | 1999-06-30 | 2001-11-06 | Advanced Cardiovascular Systems, Inc. | Stent design for use in small vessels |
WO2001028454A2 (en) * | 1999-10-05 | 2001-04-26 | Amjad Ahmad | Intra vascular stent |
US20020049490A1 (en) * | 2000-04-11 | 2002-04-25 | Pollock David T. | Single-piece endoprosthesis with high expansion ratios |
US6764507B2 (en) * | 2000-10-16 | 2004-07-20 | Conor Medsystems, Inc. | Expandable medical device with improved spatial distribution |
US6547818B1 (en) * | 2000-10-20 | 2003-04-15 | Endotex Interventional Systems, Inc. | Selectively thinned coiled-sheet stents and methods for making them |
US6626935B1 (en) * | 2000-12-21 | 2003-09-30 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
-
2001
- 2001-01-18 US US09/765,725 patent/US6558415B2/en not_active Expired - Lifetime
-
2002
- 2002-01-18 EP EP10186236A patent/EP2298240A3/en not_active Withdrawn
- 2002-01-18 AU AU2002237877A patent/AU2002237877A1/en not_active Abandoned
- 2002-01-18 EP EP10186231.6A patent/EP2289465B1/en not_active Expired - Lifetime
- 2002-01-18 EP EP02704180.5A patent/EP1351625B1/en not_active Expired - Lifetime
- 2002-01-18 WO PCT/US2002/001597 patent/WO2002056795A2/en not_active Application Discontinuation
- 2002-01-18 ES ES02704180.5T patent/ES2513065T3/en not_active Expired - Lifetime
-
2003
- 2003-08-14 US US10/389,273 patent/US20030229391A1/en not_active Abandoned
-
2006
- 2006-09-20 US US11/533,591 patent/US20070088429A1/en not_active Abandoned
-
2009
- 2009-11-02 US US12/611,114 patent/US9034029B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5733303A (en) * | 1994-03-17 | 1998-03-31 | Medinol Ltd. | Flexible expandable stent |
US6520985B1 (en) * | 1998-03-27 | 2003-02-18 | Cordis Corporation | Stent with reduced shortening |
US6540774B1 (en) * | 1999-08-31 | 2003-04-01 | Advanced Cardiovascular Systems, Inc. | Stent design with end rings having enhanced strength and radiopacity |
US6423090B1 (en) * | 2000-02-11 | 2002-07-23 | Advanced Cardiovascular Systems, Inc. | Stent pattern with staged expansion |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9173973B2 (en) | 2006-07-20 | 2015-11-03 | G. Lawrence Thatcher | Bioabsorbable polymeric composition for a medical device |
US20110208294A1 (en) * | 2006-10-20 | 2011-08-25 | Orbusneich Medical, Inc. | Bioabsorbable medical device with coating |
US8642068B2 (en) * | 2006-10-20 | 2014-02-04 | Orbusneich Medical, Inc. | Bioabsorbable medical device with coating |
US20140135901A1 (en) * | 2006-10-20 | 2014-05-15 | Orbusneich Medical, Inc. | Bioabsorbable medical device with coating |
US9211205B2 (en) * | 2006-10-20 | 2015-12-15 | Orbusneich Medical, Inc. | Bioabsorbable medical device with coating |
US9724864B2 (en) | 2006-10-20 | 2017-08-08 | Orbusneich Medical, Inc. | Bioabsorbable polymeric composition and medical device |
US20090041978A1 (en) * | 2007-02-05 | 2009-02-12 | Sogard David J | Synthetic composite structures |
US20170007400A1 (en) * | 2007-02-05 | 2017-01-12 | Boston Scientific Scimed, Inc. | Synthetic composite structures |
US10314700B2 (en) * | 2007-02-05 | 2019-06-11 | Boston Scientific Scimed, Inc. | Synthetic composite structures |
US9066825B2 (en) | 2012-05-14 | 2015-06-30 | C.R. Bard, Inc. | Uniformly expandable stent |
US10588765B2 (en) | 2012-05-14 | 2020-03-17 | C. R. Bard, Inc. | Uniformly expandable stent |
USD723165S1 (en) | 2013-03-12 | 2015-02-24 | C. R. Bard, Inc. | Stent |
Also Published As
Publication number | Publication date |
---|---|
WO2002056795A2 (en) | 2002-07-25 |
US9034029B2 (en) | 2015-05-19 |
EP2289465B1 (en) | 2018-05-30 |
US6558415B2 (en) | 2003-05-06 |
ES2513065T3 (en) | 2014-10-24 |
US20070088429A1 (en) | 2007-04-19 |
EP2289465A2 (en) | 2011-03-02 |
EP1351625B1 (en) | 2014-07-23 |
EP2289465A3 (en) | 2011-10-05 |
WO2002056795A3 (en) | 2003-02-27 |
EP2298240A3 (en) | 2011-10-05 |
AU2002237877A1 (en) | 2002-07-30 |
EP2298240A2 (en) | 2011-03-23 |
US20010029397A1 (en) | 2001-10-11 |
US20100228338A1 (en) | 2010-09-09 |
EP1351625A2 (en) | 2003-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6558415B2 (en) | Stent | |
US6132461A (en) | Stent with dual support structure | |
US6358274B1 (en) | Stent | |
EP1427352B1 (en) | Stent with offset cell geometry | |
US6551351B2 (en) | Spiral wound stent | |
EP1155664B1 (en) | A helical stent having flat ends | |
EP2311412B2 (en) | Stent having helical elements | |
US6805704B1 (en) | Intraluminal stents | |
US20140107765A1 (en) | Self-expanding stent | |
US20010016770A1 (en) | Stent with reinforced struts and bimodal deployment | |
US20070135891A1 (en) | Stent having an expandable web structure | |
JP2003500101A (en) | Expandable medical device with ductile hinge | |
JPH08507243A (en) | Flexible stent with pattern formed from sheet material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: EV3 PERIPHERAL, INC., MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:SULZER INTRA THERAPEUTICS, INC.;REEL/FRAME:014312/0533 Effective date: 20021227 Owner name: SULZER INTRATHERAPEUTICS, INC., MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:INTRATHERAPEUTICS, INC.;REEL/FRAME:014312/0519 Effective date: 20010201 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |